Ignite Creation Date:
2024-10-25 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06584123
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-24
Brief Title:
Molecular Pituitary Imaging Using 18F-FET PET
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Exploring the Potential for 18F-fluoro-ethyl-tyrosine 18F-FET to Enable Wider Access to Molecular Imaging for Patients With Pituitary Adenomas FET-pit-PET Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FET-pit-PET
Brief Summary:
The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET FET-PET yields comparable findings to 11C-methionine PET Met-PET for the localisation of pituitary tumours
Detailed Description:
Up to 20 patients with pituitary adenomas PA who have previously undergone 11C-methionine PET Met-PET as part of routine clinical care will undergo 18F-fluoroethyltyrosine PET FET-PET Patients with newly diagnosed PA or residualrecurrent pituitary tumours following previous treatment will be eligible for recruitment to the study
Quantitative and qualitative analyses will be performed to assess whether MET-PET and FET-PET yield comparable findings in patients with newly diagnosed or recurrent PA
Quantitative and qualitative analyses will be performed to assess whether MET-PET and FET-PET yield comparable findings in patients with newly diagnosed or recurrent PA
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None